Ása Karlsdóttir

930 citations

36 papers · 668 indexed · h-index 16

Pulmonary and Respiratory Medicine top 10%
Surgery top 10%
Radiation top 2%
Radiology, Nuclear Medicine and Imaging top 10%
Rheumatology top 10%

Co-authors: L.P. Muren Olav Dahl Tore Wentzel‐Larsen Dag Clement Johannessen Hege Sagstuen Haugnes Yngve Kvinnsland Torgrim Tandstad Maria Thor
Topics: Testicular diseases and treatments (14 papers)Advanced Radiotherapy Techniques (12 papers)Prostate Cancer Diagnosis and Treatment (10 papers)
Cited by: Radiation Otorhinolaryngology Pulmonary and Respiratory Medicine
Journals: Journal of Clinical Oncology PLoS ONE Scientific Reports
Partner nations: Norway Sweden Denmark

In The Last Decade

Ása Karlsdóttir

33 papers receiving 660 citations

Peers

Countries citing papers authored by Ása Karlsdóttir

Since Specialization

Citations

This map shows the geographic impact of Ása Karlsdóttir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ása Karlsdóttir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ása Karlsdóttir more than expected).

Fields of papers citing papers by Ása Karlsdóttir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ása Karlsdóttir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ása Karlsdóttir. The network helps show where Ása Karlsdóttir may publish in the future.

Co-authorship network of co-authors of Ása Karlsdóttir

This figure shows the co-authorship network connecting the top 25 collaborators of Ása Karlsdóttir. A scholar is included among the top collaborators of Ása Karlsdóttir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ása Karlsdóttir. Ása Karlsdóttir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Penile Cancer Distant Metastasis or Primary Lung Cancer? Using Focused Genomic Profiling of Tumor and Germline Mutations With Next‐Generation Sequencing for Clinical Decision‐Making 2025 ·Cancer Reports ·(unknown),(unknown),Ása Karlsdóttir,(unknown),(unknown),(unknown),Torjan Haslerud,(unknown),(unknown),Christian Beisland,Hildegunn Høberg‐Vetti,(unknown),(unknown)	0
2	Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours 2024 ·British Journal of Urology ·Axel Gerdtsson,Helene F. S. Negaard,(unknown),(unknown),(unknown),Ingrid Glimelius,(unknown),Hege Sagstuen Haugnes,(unknown),(unknown),(unknown),Ása Karlsdóttir,Anders Kjellman,(unknown),(unknown),Rolf Wahlqvist,Olof Ståhl,Torgrim Tandstad	1
3	Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients 2023 ·British Journal of Urology ·Axel Gerdtsson,Gustav Torisson,(unknown),(unknown),(unknown),Ulf Håkansson,Magnus Törnblom,Helene F. S. Negaard,Ingrid Glimelius,(unknown),Ása Karlsdóttir,Hege Sagstuen Haugnes,(unknown),(unknown),Rolf Wahlqvist,Torgrim Tandstad,(unknown),Olof Ståhl,Anders Kjellman	2
4	Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group 2021 ·European Urology Oncology ·Axel Gerdtsson,(unknown),(unknown),(unknown),Ulf Håkansson,Magnus Törnblom,Helene F. S. Negaard,Ingrid Glimelius,(unknown),Ása Karlsdóttir,Hege Sagstuen Haugnes,(unknown),(unknown),(unknown),Rolf Wahlqvist,Torgrim Tandstad,Gabriella Cohn‐Cedermark,Olof Ståhl,Anders Kjellman	15
5	Characteristics and prognosis of primary treatment-naïve oral cavity squamous cell carcinoma in Norway, a descriptive retrospective study 2020 ·PLoS ONE ·(unknown),(unknown),(unknown),Ása Karlsdóttir,(unknown),Lars Uhlin‐Hansen,Oddveig Rikardsen,Elin Hadler‐Olsen,Sonja E. Steigen	22
6	Quantitative PCR Measurement of miR-371a-3p and miR-372-p Is Influenced by Hemolysis 2019 ·Frontiers in Genetics ·(unknown),(unknown),Peder Gjengstø,(unknown),Ása Karlsdóttir,Marianne Brydøy,Olav Dahl	33
7	Inter-institutional analysis demonstrates the importance of lower than previously anticipated dose regions to prevent late rectal bleeding following prostate radiotherapy 2018 ·Radiotherapy and Oncology ·Maria Thor,Andrew Jackson,Michael J. Zeléfsky,Gunnar Steineck,Ása Karlsdóttir,Morten Høyer,Mitchell Liu,Nicola J. Nasser,(unknown),Vitali Moiseenko,Joseph O. Deasy	11
8	Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA) 2016 ·Annals of Oncology ·Torgrim Tandstad,O. Ståhl,O. Dahl,Hege Sagstuen Haugnes,Ulf Håkansson,Ása Karlsdóttir,Anders Kjellman,Carl W. Langberg,A. Laurell,Jan Oldenburg,A. Solberg,Karin Söderström,Ulrika Stierner,Eva Cavallin‐Ståhl,Rolf Wahlqvist,Najme Wall,Gabriella Cohn‐Cedermark	67
9	Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status 2016 ·European Archives of Oto-Rhino-Laryngology ·(unknown),(unknown),(unknown),Ása Karlsdóttir,Olav Karsten Vintermyr,Hans Jørgen Aarstad	22
10	The impact of HPV infection, smoking history, age and operability of the patient on disease-specific survival in a geographically defined cohort of patients with oropharyngeal squamous cell carcinoma 2014 ·Acta Oto-Laryngologica ·(unknown),(unknown),(unknown),(unknown),(unknown),Ása Karlsdóttir,Olav Karsten Vintermyr,Hans Jørgen Aarstad	21
11	Prediction of rectum and bladder morbidity following radiotherapy of prostate cancer based on motion-inclusive dose distributions 2013 ·Radiotherapy and Oncology ·Maria Thor,Lise Bentzen,L.B. Hysing,(unknown),(unknown),Ása Karlsdóttir,L.P. Muren	30
12	Dose/volume–response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions 2013 ·Radiotherapy and Oncology ·Maria Thor,Aditya Apte,Joseph O. Deasy,Ása Karlsdóttir,Vitali Moiseenko,Mitchell Liu,L.P. Muren	22
13	Rectum motion and morbidity prediction: Improving correlation between late morbidity and DVH parameters through use of rectum planning organ at risk volumes 2010 ·Acta Oncologica ·Maria Thor,Michael Væth,Ása Karlsdóttir,L.P. Muren	13
14	Intensity-Modulated Radiotherapy of Pelvic Lymph Nodes in Locally Advanced Prostate Cancer: Planning Procedures and Early Experiences 2008 ·International Journal of Radiation OncologyBiologyPhysics ·L.P. Muren,(unknown),Svein Inge Helle,L.B. Hysing,Ása Karlsdóttir,O.H. Odland,(unknown),(unknown),Dag Clement Johannessen	44
15	Late Gastrointestinal Morbidity After Three-Dimensional Conformal Radiation Therapy for Prostate Cancer Fades With Time in Contrast to Genitourinary Morbidity 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Ása Karlsdóttir,L.P. Muren,Tore Wentzel‐Larsen,Olav Dahl	39
16	Testing the new ICRU 62 ‘Planning Organ at Risk Volume’ concept for the rectum 2005 ·Radiotherapy and Oncology ·L.P. Muren,Ása Karlsdóttir,Yngve Kvinnsland,Tore Wentzel‐Larsen,Olav Dahl	31
17	On the use of margins for geometrical uncertainties around the rectum in radiotherapy planning 2004 ·Radiotherapy and Oncology ·L.P. Muren,(unknown),Yngve Kvinnsland,Ása Karlsdóttir,Olav Dahl	38
18	Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer 2004 ·Radiotherapy and Oncology ·Ása Karlsdóttir,Dag Clement Johannessen,L.P. Muren,Tore Wentzel‐Larsen,Olav Dahl	68
19	Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers 2004 ·Scandinavian Journal of Gastroenterology ·A. Larsen,N Hovdenak,Ása Karlsdóttir,Tore Wentzel‐Larsen,Olav Dahl,Magne K. Fagerhol	25
20	Profiles and Time Course of Acute Radiation Toxicity Symptoms during Conformal Radiotherapy for Cancer of the Prostate 2003 ·Acta Oncologica ·N Hovdenak,Ása Karlsdóttir,Halfdan Sørbye,Olav Dahl	15

About Ása Karlsdóttir

Ása Karlsdóttir is a scholar working on Radiation, Reproductive Medicine and Otorhinolaryngology, having authored 36 papers that have together received 668 indexed citations. Recurring topics across this work include Testicular diseases and treatments (14 papers), Advanced Radiotherapy Techniques (12 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). The work is most often cited by research in Radiation (258 citations), Otorhinolaryngology (50 citations) and Pulmonary and Respiratory Medicine (359 citations). Ása Karlsdóttir has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include L.P. Muren, Olav Dahl, Tore Wentzel‐Larsen, Dag Clement Johannessen, Hege Sagstuen Haugnes, Yngve Kvinnsland, Torgrim Tandstad, Maria Thor, L.B. Hysing and Anders Kjellman. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact